| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 214.15B | 216.92B | 194.03B | 172.10B | 173.57B | 195.69B |
| Gross Profit | 34.33B | 34.31B | 28.51B | 23.92B | 21.66B | 28.86B |
| EBITDA | 25.26B | 24.68B | 19.22B | 14.64B | 12.08B | 19.04B |
| Net Income | 13.83B | 13.19B | 10.04B | 7.17B | 5.22B | 9.55B |
Balance Sheet | ||||||
| Total Assets | 258.08B | 296.39B | 282.60B | 261.37B | 257.70B | 265.66B |
| Cash, Cash Equivalents and Short-Term Investments | 32.47B | 27.17B | 36.21B | 42.34B | 45.29B | 42.76B |
| Total Debt | 5.35B | 5.06B | 1.06B | 863.00M | 1.04B | 1.06B |
| Total Liabilities | 52.44B | 86.73B | 83.48B | 71.14B | 72.51B | 81.29B |
| Stockholders Equity | 191.99B | 195.72B | 185.79B | 177.23B | 172.37B | 171.54B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -9.12B | 3.76B | -93.00M | 6.80B | 13.66B |
| Operating Cash Flow | 0.00 | -4.34B | 7.38B | 13.23B | 9.51B | 19.57B |
| Investing Cash Flow | 0.00 | -5.77B | -4.18B | -12.44B | -6.64B | -9.40B |
| Financing Cash Flow | 0.00 | 169.00M | -7.93B | -2.34B | -2.74B | -2.74B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | ¥183.26B | 11.69 | ― | 2.81% | 8.83% | 49.49% | |
76 Outperform | ¥194.75B | 6.20 | ― | 2.72% | -2.11% | -11.31% | |
76 Outperform | ¥266.19B | 12.19 | 7.43% | 2.78% | 1.31% | 59.20% | |
76 Outperform | ¥320.27B | 9.48 | ― | 2.79% | 10.62% | 64.25% | |
71 Outperform | ¥188.04B | 9.99 | ― | 2.87% | 6.66% | 46.38% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |